Inogen Inc (INGN) is a publicly traded Healthcare sector company. As of July 16, 2026, INGN trades at $6.61 with a market cap of $171.38M and a P/E ratio of -6.89. INGN moved +2.11% today. Year to date, INGN is -4.61%; over the trailing twelve months it is -2.14%. Its 52-week range spans $5.34 to $12.91. Analyst consensus is buy with an average price target of $12.00. Rallies surfaces INGN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks the latest INGN news, catalysts, market updates, source links, and AI summaries when news is available.
| Metric | Value |
|---|---|
| Price | $6.61 |
| Market Cap | $171.38M |
| P/E Ratio | -6.89 |
| EPS | $-0.92 |
| Dividend Yield | 0.00% |
| 52-Week High | $12.91 |
| 52-Week Low | $5.34 |
| Volume | 52.97K |
| Avg Volume | 0 |
| Revenue (TTM) | $351.50M |
| Net Income | $-24.90M |
| Gross Margin | 44.31% |
1 analysts cover INGN: 0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $12.00.